Frost & Sullivan

MARCH 28, 2025

Download our full analysis on the top 6 growth opportunities in pharma and biotech. By 2030, the RLT market is projected to reach $13.07 Key Growth Opportunities Strategic Partnerships: Collaborations like Sanofis licensing deal with RadioMedix and Orano Med demonstrate the potential for RLT expansion into rare cancers.

Biotech 52

Biotech Biotechnology Strategic partnership Insurance 52

Frost & Sullivan

MARCH 26, 2025

As agrochemical companies embrace biotech innovations and AI-driven solutions, the market is witnessing a shift toward more efficient, sustainable, and high-performance agricultural inputs. The integration of biotech in agrochemicals enables the development of resilient crops, while AI-powered analytics enhance precision farming techniques.

Biotech 52

Biotech Mergers and acquisition activities Collaboration 52

Frost & Sullivan

APRIL 14, 2025

By 2030, the sector is projected to generate an additional $3 billion in revenue. Internal Challenges Corporate Cultural Shift to Embrace Rapid Biotech Innovation Adapting to fast-paced biotech advances requires an organizational culture that fosters agility, experimentation, and cross-disciplinary collaboration.

Biotech 52

Biotech Engineering Ecosystems Collaboration 52

Frost & Sullivan

MARCH 13, 2025

Rigetti Computing: Focused on building quantum computing systems, Rigetti is collaborating with medical institutions to apply quantum algorithms for real-time surgical data processing. Click here to download How can digital transformation in surgery address current healthcare challenges and improve patient outcomes? Want deeper insights?

Biotech 52

Biotech Utilities Strategic partnership Ecosystems 52